Gut microbiota (GMB) and osteoarthritis (OA) management: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing. Chairperson: Sansin TUZUN ‣ Introduction - René RIZZOLI ‣ Role of gut microbiota in non-communicable disease and osteoarthritis management - René RIZZOLI ‣ Gut microbiota and inflammation - Claudio FRANCESCHI ‣ Conclusion - René RIZZOLI
Algorithm for the use of biochemical markers of bone turnover in the diagnosis and follow-up of treatment for osteoporosis: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing Chairperson: Adolfo DIEZ PEREZ ‣ Introduction - John A. KANIS ‣ Clinical application of bone turnover markers in post-menopausal osteoporosis - Mattias LORENTZON ‣ Algorithm for the assessment of anti-osteoporosis treatments by bone turnover markers - Eugene MCCLOSKEY ‣ Conclusion - Eugene MCCLOSKEY
Chairperson: Sansin TUZUN
‣ Introduction - René RIZZOLI
‣ Role of gut microbiota in non-communicable disease and osteoarthritis management - René RIZZOLI
‣ Gut microbiota and inflammation - Claudio FRANCESCHI
‣ Conclusion - René RIZZOLI
Algorithm for the use of biochemical markers of bone turnover in the diagnosis and follow-up of treatment for osteoporosis: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculoskeletal Health and Ageing
Chairperson: Adolfo DIEZ PEREZ
‣ Introduction - John A. KANIS
‣ Clinical application of bone turnover markers in post-menopausal osteoporosis - Mattias LORENTZON
‣ Algorithm for the assessment of anti-osteoporosis treatments by bone turnover markers - Eugene MCCLOSKEY
‣ Conclusion - Eugene MCCLOSKEY